 | |
| Clinical data | |
|---|---|
| Other names | α,β-D; α,β-Dideuteromescaline; α,β-Dideutero-3,4,5-trimethoxyphenethylamine |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | Somewhat more rapid than mescaline |
| Duration of action | Unknown |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C11H15D2NO3 |
| Molar mass | 213.272 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Alpha,Beta-D, or α,β-D, also known as α,β-dideuteromescaline, is a psychedelic drug of the phenethylamine and scaline families related to mescaline. It is the deuterated isotopologue of mescaline in which one hydrogen atom at the α position and one hydrogen atom at the β position have been replaced with the deuterium isotopes.
According to Daniel Trachsel in his book Phenethylamine: von der Struktur zur Funktion (Phenethylamines: From Structure to Function), α,β-D at a dose of 250 mg orally produces effects comparable to an equivalent dose of mescaline, but had a somewhat more rapid onset. This information was based on anonymous personal communication to Trachsel in 2009. The similar potency of α,β-D to mescaline is in contrast to the case of α-D (α,α-dideuteromescaline), which was reported to be roughly one-third more potent than mescaline based on limited testing.
The chemical synthesis of α,β-D has been described. It has four possible theoretical stereoisomers.
α,β-D was first described in the scientific literature by Trachsel in his book in 2013.